MADRIGAL PHARMACEUTICALS, INC. short interest in 2022
In 2022, MADRIGAL PHARMACEUTICALS, INC.'s disclosed short interest ran from 8.75% of shares outstanding on 14 Jan 2022 to 6.54% on 30 Dec 2022, a change of -2.21 percentage points. The year's high was 13.87% on 15 Dec 2022 and its low 6.54% on 30 Dec 2022, averaging 10.08% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.90 days on 31 Mar 2022. Full history: MADRIGAL PHARMACEUTICALS, INC..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 8.75% (14 Jan 2022)
- End of year
- 6.54% (30 Dec 2022)
- Change
- -2.21 pp
- High
- 13.87% (15 Dec 2022)
- Low
- 6.54% (30 Dec 2022)
- Average
- 10.08%
- Highest days to cover
- 11.90 (31 Mar 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 8.75% | 8.65 | |
| 31 Jan 2022 | 10.49% | 5.27 | |
| 15 Feb 2022 | 11.77% | 5.72 | |
| 28 Feb 2022 | 11.60% | 9.63 | 10-K filed, results (8-K) |
| 15 Mar 2022 | 11.63% | 11.59 | |
| 31 Mar 2022 | 10.59% | 11.90 | |
| 14 Apr 2022 | 10.00% | 8.17 | |
| 29 Apr 2022 | 10.19% | 10.24 | |
| 13 May 2022 | 9.88% | 5.96 | 10-Q filed, results (8-K) |
| 31 May 2022 | 9.33% | 10.84 | |
| 15 Jun 2022 | 9.68% | 9.61 | |
| 30 Jun 2022 | 9.45% | 7.89 | |
| 15 Jul 2022 | 9.04% | 8.46 | |
| 29 Jul 2022 | 9.38% | 10.09 | |
| 15 Aug 2022 | 9.00% | 8.06 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 8.60% | 8.49 | |
| 15 Sep 2022 | 8.73% | 6.50 | |
| 30 Sep 2022 | 8.93% | 5.79 | |
| 14 Oct 2022 | 9.06% | 5.21 | |
| 31 Oct 2022 | 10.66% | 6.83 | |
| 15 Nov 2022 | 12.14% | 7.89 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 12.66% | 7.70 | |
| 15 Dec 2022 | 13.87% | 5.20 | |
| 30 Dec 2022 | 6.54% | 1.00 |
See also: MADRIGAL PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.